dpp4 and glp 1 mechanism of action for GIP, GLP-1 analogues inhibitors in The multiple actions of dipeptidyl

Symptoms of deficiency can occur gradually and can be overlooked until they become severe

"TYR"

This review synthesizes emerging evidence on glucagons regulatory mechanisms, multi-organ effects, and translational implications, positioning glucagon as a central pathophysiological mediator beyond glycemic control ( Figure 2 )

moreover, similar GLP-1RA effect sizes suggest a lack of sufficient power rather than a lack of effect

Ogilvie P, Thulesen J, Leys C, et al

These studies therefore formed firm evidence for the concept that DPP-4 inhibition may be beneficial in reducing glucose and the studies in animals formed a foundation for the proceeding to test the idea in humans